Haleon (HLN) Common Equity (2021 - 2026)
Haleon's (HLN) quarterly Common Equity came in at $22.1 billion in Q2 2026, little changed on a QoQ basis from $22.1 billion in Q4 2025.
Haleon (HLN) Common Equity (2021 - 2026) Analysis & Trends
Haleon (HLN) has 6 years of Common Equity data on file, last reported at $22.1 billion in Q2 2026.
- Quarterly Common Equity changed N/A year-over-year to $22.1 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $22.1 billion (changed N/A YoY) and the FY2025 annual result came in at $21.9 billion, up 5.73% from the prior year.
- Common Equity steadied at $22.1 billion in Q2 2026, from $22.1 billion in the prior quarter.
- In the past five years, Common Equity ranged from a high of $34.0 billion in Q2 2022 to a low of $19.3 billion in Q4 2022.
- A 5-year average of $22.6 billion and a median of $21.0 billion in 2024 frame the typical range for Common Equity.
- Annual changes were most pronounced in 2022 — Common Equity slumped 45.92% — and 2023, when it rose 7.57%.
- Tracing HLN's Common Equity over 5 years: stood at $19.3 billion in 2022, then grew by 7.57% to $20.8 billion in 2023, then climbed by 0.29% to $20.8 billion in 2024, then grew by 6.06% to $22.1 billion in 2025, then slipped by 0.13% to $22.1 billion in 2026.
- The last three Common Equity figures came in at $22.1 billion (Q2 2026), $22.1 billion (Q4 2025), and $20.8 billion (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | 22.06 Bn |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 7.76 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 3.15 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 47.42 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 6.40 Bn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 14.26 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 3.69 Bn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 6.59 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | 4.05 Bn |
| 10 | Alkermes | 8.20 Bn | 7.54 Bn | 397.90 Mn | 1.81 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 22.06 Bn |
| Dec 31, 2025 | 22.09 Bn |
| Dec 31, 2024 | 20.82 Bn |
| Jun 30, 2024 | 21.09 Bn |
| Dec 31, 2023 | 20.76 Bn |
| Jun 30, 2023 | 20.73 Bn |
| Dec 31, 2022 | 19.30 Bn |
| Jun 30, 2022 | 34.00 Bn |
| Dec 31, 2021 | 35.70 Bn |